Creative Biolabs-Immuno-oncology

Anti-CD19 (clone h1G1G9Qa) SynExpress T7-Cy3-I10-X Modified CD8+ T cells (CAT#: ITS-1224-CR938)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD19 (clone h1G1G9Qa). We employs the pCDNA (T7-Cy3-IL-10-XbaI) vector components and the SynExpress system of the Exons Deletion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD19
Clone
h1G1G9Qa
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
IL-10
Insertion Sites
XbaI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
pCDNA
Transformation Accuracy
0.92
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving